The annual and no-commitment options are clearly different purchases.

Our Trimi review separates what the provider currently publishes from what still needs a personal quote or clinical assessment. Sources were checked September 19, 2026; advertised availability and pricing can change.

The quick read

  • The annual and no-commitment options are clearly different purchases.
  • Semaglutide is $1,188 billed upfront for twelve months, displayed as $99 per month, or $175 monthly without that commitment. Tirzepatide is $1,500 upfront for twelve months, displayed as $125 per month, or $235 monthly. The annual equivalent should always travel with the upfront total.
  • How are unused annual payments handled after a medical change, and how often is my treatment reassessed?

What the current public pages establish

Trimi’s home page describes compounded semaglutide and tirzepatide plans including medication if prescribed, supplies, provider care and shipping. It presents annual prepayment and month-to-month alternatives separately.

This review concerns the public offer at the sources below, checked September 19, 2026. It is not a patient-experience review. We have not enrolled, obtained a prescription, contacted the care team as a patient or measured service quality. Where a detail remains unconfirmed, we leave it open rather than filling it from an old comparison.

What the price includes—and what to confirm

Semaglutide is $1,188 billed upfront for twelve months, displayed as $99 per month, or $175 monthly without that commitment. Tirzepatide is $1,500 upfront for twelve months, displayed as $125 per month, or $235 monthly. The annual equivalent should always travel with the upfront total.

For a usable quote, write down the amount due today, payment interval, medication quantity, length of the commitment and next renewal. Add consultation, ongoing care, laboratory, shipping and pharmacy charges wherever they are separate. Our GLP-1 cost guide explains how to put those amounts on the same basis.

The decision that deserves a closer look

Clearer advertised pricing makes it easier to ask the next question: what happens when circumstances change? Confirm cancellation, unused-payment refunds and shipment timing. Also ask how the clinician reassesses treatment over a long prepaid period; paying for a year does not settle what will be medically appropriate throughout that year.

Before the consultation

Bring one specific question to Trimi: How are unused annual payments handled after a medical change, and how often is my treatment reassessed?

Also ask who will be prescribing, which pharmacy will dispense, how you reach the clinical team, and who handles a delayed shipment or a problem with the label. Request the payment and cancellation terms in writing. A customer-support promise and a clinical appointment are different services, so confirm how each works. Our first appointment guide can help you prepare your medical history and existing medication list.

Prescription and evidence boundaries

A provider listing is not a prescription or an endorsement of a particular treatment. Compounded products are not FDA-approved, and evidence for an approved medicine does not automatically establish the safety or effectiveness of another formulation. See the compounded-versus-approved guide for those distinctions.

Use the exact medication and route when discussing suitability with your clinician. Ask the dispensing pharmacy to explain its label, storage directions and what to do if delivery conditions are questionable. General website instructions should not replace the instructions for your own prescription.

Compare the care you would actually receive

Use the same questions with another service before deciding. The CoreAge Rx review describes our featured commercial partner, and the MEDVi review explores another care or payment model. CoreAge Rx’s featured placement is commercial and does not establish clinical superiority.

Compare the complete written offers, the kind of clinician access you want, and the plan for follow-up. If a provider cannot clarify the medicine, the total payment obligation or who is responsible for continuing care, resolve those questions before enrolling. The provider verification guide gives you a practical next step.

Sources & reading notes

Public materials checked September 19, 2026. Provider pages establish advertised terms, not independent proof of outcomes or service quality. Clinical information is general and is not personal medical advice. No clinician review of this article is claimed.

  1. Trimi — official program page
  2. Trimi — official supporting source
  3. FDA: concerns about unapproved GLP-1 drugs
  4. FDA BeSafeRx: online pharmacy information

How we research · How commercial placement works